Copyright
©The Author(s) 2023.
World J Gastroenterol. May 7, 2023; 29(17): 2515-2533
Published online May 7, 2023. doi: 10.3748/wjg.v29.i17.2515
Published online May 7, 2023. doi: 10.3748/wjg.v29.i17.2515
Figure 1 Proposed design of circulating tumor DNA-guided treatment strategy in gastric cancer.
Schematic presentation of proposed circulating tumor DNA (ctDNA) guided treatment strategy in gastric cancer evaluating tailored treatment based on ctDNA detection. ctDNA positivity was determined by accessing the presence of plasma mutations, which indicates the existence of minimal residual disease. Adapted from Chakrabarti et al[100], and Kasi et al[101]. ctDNA: Circulating tumor DNA; Op: Operative; Adj: Ajuvant chemotherapy.
- Citation: Matsuoka T, Yashiro M. Novel biomarkers for early detection of gastric cancer. World J Gastroenterol 2023; 29(17): 2515-2533
- URL: https://www.wjgnet.com/1007-9327/full/v29/i17/2515.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i17.2515